Sepsis Important Genes Identification Through Biologically Informed Deep Learning and Transcriptomic Analysis

IF 2.9 4区 医学 Q2 Medicine
Ruichen Li, Qiushi Wang, Ru Gao, Rutao Shen, Qihao Wang, Xiuliang Cui, Zhiming Jiang, Lijie Zhang, Jingjing Fang
{"title":"Sepsis Important Genes Identification Through Biologically Informed Deep Learning and Transcriptomic Analysis","authors":"Ruichen Li,&nbsp;Qiushi Wang,&nbsp;Ru Gao,&nbsp;Rutao Shen,&nbsp;Qihao Wang,&nbsp;Xiuliang Cui,&nbsp;Zhiming Jiang,&nbsp;Lijie Zhang,&nbsp;Jingjing Fang","doi":"10.1111/1440-1681.70031","DOIUrl":null,"url":null,"abstract":"<div>\n \n <p>Sepsis is a life-threatening disease caused by the dysregulation of the immune response. It is important to identify influential genes modulating the immune response in sepsis. In this study, we used P-NET, a biologically informed explainable artificial intelligence model, to evaluate the gene importance for sepsis. About 688 important genes were identified, and these genes were enriched in pathways involved in inflammation and immune regulation, such as the PI3K-Akt signalling pathway, necroptosis and the NF-κB signalling pathway. We further selected differentially expressed genes both at bulk and single-cell levels and found TIMP1, GSTO1 and MYL6 exhibited significant different expressions in multiple cell types. Moreover, the expression levels of these 3 genes were correlated with the abundance of important immune cells, such as M-MDSC cells. Further analysis demonstrated that these three genes were highly expressed in sepsis patients with worse outcomes, such as severe, non-survived and shock sepsis patients. Using a drug repositioning strategy, we found navitoclax, curcumin and rotenone could down-regulate and bind to these genes. In conclusion, TIMP1, GSTO1 and MYL6 may serve as promising biomarkers and targets for sepsis treatment.</p>\n </div>","PeriodicalId":50684,"journal":{"name":"Clinical and Experimental Pharmacology and Physiology","volume":"52 7","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Pharmacology and Physiology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/1440-1681.70031","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

Abstract

Sepsis is a life-threatening disease caused by the dysregulation of the immune response. It is important to identify influential genes modulating the immune response in sepsis. In this study, we used P-NET, a biologically informed explainable artificial intelligence model, to evaluate the gene importance for sepsis. About 688 important genes were identified, and these genes were enriched in pathways involved in inflammation and immune regulation, such as the PI3K-Akt signalling pathway, necroptosis and the NF-κB signalling pathway. We further selected differentially expressed genes both at bulk and single-cell levels and found TIMP1, GSTO1 and MYL6 exhibited significant different expressions in multiple cell types. Moreover, the expression levels of these 3 genes were correlated with the abundance of important immune cells, such as M-MDSC cells. Further analysis demonstrated that these three genes were highly expressed in sepsis patients with worse outcomes, such as severe, non-survived and shock sepsis patients. Using a drug repositioning strategy, we found navitoclax, curcumin and rotenone could down-regulate and bind to these genes. In conclusion, TIMP1, GSTO1 and MYL6 may serve as promising biomarkers and targets for sepsis treatment.

Abstract Image

通过生物学深度学习和转录组学分析鉴定脓毒症重要基因
败血症是一种由免疫反应失调引起的危及生命的疾病。确定在败血症中调节免疫反应的有影响的基因是很重要的。在这项研究中,我们使用P-NET(一种具有生物学知识的可解释人工智能模型)来评估基因对败血症的重要性。共鉴定出688个重要基因,这些基因富集在参与炎症和免疫调节的通路中,如PI3K-Akt信号通路、坏死性凋亡通路和NF-κB信号通路。我们进一步在大细胞和单细胞水平上选择差异表达基因,发现TIMP1、GSTO1和MYL6在多种细胞类型中表现出显著差异表达。此外,这3个基因的表达水平与重要免疫细胞(如M-MDSC细胞)的丰度相关。进一步分析表明,这三个基因在脓毒症患者中高度表达,结果较差,如严重、未存活和休克脓毒症患者。使用药物重新定位策略,我们发现navitoclax,姜黄素和鱼藤酮可以下调并结合这些基因。综上所述,TIMP1、GSTO1和MYL6可能是脓毒症治疗的有希望的生物标志物和靶点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.20
自引率
0.00%
发文量
128
审稿时长
6 months
期刊介绍: Clinical and Experimental Pharmacology and Physiology is an international journal founded in 1974 by Mike Rand, Austin Doyle, John Coghlan and Paul Korner. Our focus is new frontiers in physiology and pharmacology, emphasizing the translation of basic research to clinical practice. We publish original articles, invited reviews and our exciting, cutting-edge Frontiers-in-Research series’.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信